A detailed history of Gamma Investing LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Gamma Investing LLC holds 8,232 shares of OCUL stock, worth $60,175. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,232
Previous 120 6760.0%
Holding current value
$60,175
Previous $1.03 Million 9.56%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 14, 2025

SELL
$5.93 - $9.08 $42,156 - $64,549
-7,109 Reduced 86.36%
1,123 $8.23 Million
Q1 2025

Apr 07, 2025

BUY
$5.93 - $9.08 $48,104 - $73,656
8,112 Added 6760.0%
8,232 $1.12 Million
Q4 2024

Jan 02, 2025

BUY
$8.33 - $11.47 $683 - $940
82 Added 215.79%
120 $1.03 Million
Q3 2024

Oct 04, 2024

BUY
$6.45 - $9.23 $245 - $350
38 New
38 $331,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $563M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.